Research-use compliance

Research Use Notice

This notice defines the intended research-only context for Qelivra products, information, orders, and support.

Effective August 24, 2026Version 2026-08-24.1
Research use only: not for human or veterinary use, self-experimentation, diagnosis, treatment, prevention, cure, dosing, reconstitution, injection, or clinical administration.

1. Scope and material condition of access

This notice applies to catalog access, product information, checkout, support, order fulfillment, and any other Qelivra interaction involving research supplies. The research-only limitation is a material condition of access and sale.

2. Research use only

Qelivra products and information are offered solely for lawful laboratory research. They are not intended for human or veterinary consumption, administration, self-experimentation, diagnosis, treatment, prevention, cure, or other clinical or therapeutic use.

3. No dosing, reconstitution, administration, or medical guidance

Qelivra does not provide dosing, reconstitution, mixing, injection, administration, treatment, diagnosis, medical, pharmacy, veterinary, or other human-use guidance. Support requests seeking that guidance may be declined.

4. Purchaser qualifications and responsibility

Purchasers must be of legal age, legally permitted to acquire the applicable materials, and capable of maintaining appropriate research procedures, facilities, training, storage, handling, safety, and disposal practices. The purchaser is responsible for requirements applicable to its jurisdiction, institution, workplace, carrier, or research environment.

5. No human-use resale, relabeling, or transfer

You may not resell, relabel, market, supply, transfer, or otherwise provide Qelivra products for human or veterinary use, self-experimentation, clinical administration, compounding, diagnosis, treatment, or other prohibited use. Qelivra may refuse or cancel transactions when intended use cannot be reasonably established as consistent with this policy.

6. No approval, safety, efficacy, or clinical-use representation

Qelivra does not represent that a research product is FDA-approved, cleared, authorized, safe, effective, sterile, injectable, clinically appropriate, or suitable for human or veterinary use. A vial format, product name, publication reference, or research document does not change the stated research-only intended use.

7. Product documentation and factual accuracy

Lot, testing, purity, identity, specification, storage, and other product-specific claims should appear only when supported by a verified document or supplier record applicable to that product or lot. Generic examples and renderer previews are not laboratory results or certifications.

8. Access and checkout acknowledgments

Qelivra may require versioned acknowledgments before catalog access and again before checkout. Browser-based access acknowledgment is a convenience; checkout acceptance is intended to create a transaction-specific record. A completed Stripe Checkout Session may also record acceptance of the applicable Terms.

9. Applicable law and right to refuse

Qelivra does not represent that every product or transaction is lawful in every jurisdiction. Qelivra may restrict availability, refuse fulfillment, request clarification, or cancel/refund an order when legal, regulatory, payment, fraud, safety, shipping, or intended-use concerns arise.

Nothing in this policy waives rights or obligations that cannot lawfully be waived. Qelivra may update this policy when operations or legal requirements change; the version shown at checkout controls the transaction for which it was accepted.